JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Home・Aktien・PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corp

Geschlossen

BrancheGesundheitswesen

28.49 4.74

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

28.12

Max

28.74

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.8M -21M
Verkäufe	4.1M 83M
Gewinnspanne	-25.695
Angestellte	756
EBITDA	4.8M -19M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+72.58% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	24. Feb. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-292M 1.6B
Vorheriger Eröffnungskurs	23.75
Vorheriger Schlusskurs	28.49

Nachrichtenstimmung

By Acuity

50%

142 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

52.655 / 56.31 Unterstützung & Widerstand

PROCEPT BioRobotics Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

7. Feb. 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7. Feb. 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

7. Feb. 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7. Feb. 2026, 02:46 UTC

Akquisitionen, Fusionen, Übernahmen

Big Money, High Anxiety -- Barrons.com

6. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. Feb. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

6. Feb. 2026, 21:40 UTC

Akquisitionen, Fusionen, Übernahmen

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6. Feb. 2026, 21:22 UTC

Market Talk

Mexico's Inflation Seen Accelerating in January -- Market Talk

6. Feb. 2026, 21:17 UTC

Ergebnisse

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6. Feb. 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. Feb. 2026, 21:14 UTC

Akquisitionen, Fusionen, Übernahmen

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6. Feb. 2026, 21:13 UTC

Ergebnisse

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6. Feb. 2026, 21:13 UTC

Ergebnisse

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6. Feb. 2026, 21:04 UTC

Market Talk

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6. Feb. 2026, 20:34 UTC

Ergebnisse

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

6. Feb. 2026, 20:27 UTC

Ergebnisse

These Stocks Are Today's Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More -- Barrons.com

6. Feb. 2026, 20:24 UTC

Market Talk

Oil Futures Settle Higher As U.S.-Iran Talks Get Under Way -- Market Talk

6. Feb. 2026, 20:20 UTC

Market Talk

U.S. Natural Gas Futures Retreat Ahead of Weekend -- Market Talk

6. Feb. 2026, 19:48 UTC

Ergebnisse

Take-Two, Mondelez Get Analyst Attention -- Barrons.com

6. Feb. 2026, 19:30 UTC

Akquisitionen, Fusionen, Übernahmen

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- WSJ

6. Feb. 2026, 19:30 UTC

Akquisitionen, Fusionen, Übernahmen

Justice Department Asking Industry How Netflix or Paramount Deal for Warner Bros. Might Impact Competition, According to Subpoena -- WSJ

6. Feb. 2026, 19:30 UTC

Akquisitionen, Fusionen, Übernahmen

DOJ Asking if Netflix Engaged in 'Exclusionary Conduct' That May Lead to Monopoly, According to Subpoena -- WSJ

6. Feb. 2026, 19:17 UTC

Market Talk

USDA Says Farm Income to Decrease in 2026 -- Market Talk

6. Feb. 2026, 18:50 UTC

Ergebnisse

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6. Feb. 2026, 18:47 UTC

Market Talk

Natural Gas-Infrastructure Operators Take 'Flight to Scale' -- Market Talk

6. Feb. 2026, 18:34 UTC

Market Talk

U.S. Oil Rig Count Rises By 1 to 412 -- Market Talk

6. Feb. 2026, 17:58 UTC

Ergebnisse

Reddit Stock Falls After Strong Earnings. Wall Street Is Debating What's Next. -- Barrons.com

6. Feb. 2026, 17:52 UTC

Market Talk

Ergebnisse

Global Equities Roundup: Market Talk

6. Feb. 2026, 17:52 UTC

Market Talk

Ergebnisse

Amazon's CapEx Seen as Misunderstood by Investors -- Market Talk

6. Feb. 2026, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

Peer-Vergleich

Kursveränderung

PROCEPT BioRobotics Corp Prognose

Kursziel

By TipRanks

72.58% Vorteil

12-Monats-Prognose

Durchschnitt 49.6 USD 72.58%

Hoch 62 USD

Tief 38 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für PROCEPT BioRobotics Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

6 ratings

Buy

Halten

Sell

Basierend auf 6 Analysten, die in den letzten 3 Monaten Aktienbewertungen für PROCEPT BioRobotics Corp – Dist abgegeben haben.

Technischer Score

By Trading Central

52.655 / 56.31Unterstützung & Widerstand

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Stimmung

By Acuity

142 / 352 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.